NasdaqGS - Delayed Quote USD
MBX Biosciences, Inc. (MBX)
At close: October 21 at 4:00 PM EDT
After hours: October 21 at 4:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AYNECHI TIBA Director | Purchase | Sep 16, 2024 | -- |
| BASKETT FOREST Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
| BEHBAHANI ALI Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
| CORNELIUS JAMES M Director | Conversion of Exercise of derivative security | Sep 16, 2024 | 102,082 |
| FLORENCE ANTHONY A JR Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
| GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
| HAWRYLUK P KENT Chief Executive Officer | Conversion of Exercise of derivative security | Sep 16, 2024 | -- |
| HERON PATRICK J Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
| MAKHZOUMI MOHAMAD Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
| MATHERS EDWARD T. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 16, 2024 | -- |
Related Tickers
BCAX Bicara Therapeutics Inc.
22.48
+2.37%
ZBIO Zenas BioPharma, Inc.
23.23
+8.86%
UPB Upstream Bio, Inc.
25.90
+0.08%
RAPP Rapport Therapeutics, Inc.
24.72
-4.74%
AVBP ArriVent BioPharma, Inc.
28.71
-1.54%
CGON CG Oncology, Inc.
36.71
+0.74%
ALMS Alumis Inc.
12.58
+4.57%
LXEO Lexeo Therapeutics, Inc.
10.52
-5.40%
CTNM Contineum Therapeutics, Inc.
16.07
-1.89%
BOLD Boundless Bio, Inc.
3.0300
-0.66%